Search results
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 5 days agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Your Pickleball Checklist
Prevention· 4 days agoPickleball just can’t seem to stop growing. Part of its mass appeal is its unique accessibility to all ages and skill levels, with small courts that...
Ocular Therapeutix stock target cut, Buy rating kept By Investing.com
Investing.com· 4 days agoThe biopharmaceutical company, known for its eye care treatments, has recently disclosed its...
A Dietician Explains the Difference Between Chlorella and Spirulina—Do You Know Which Is Healthier?
Health.com· 5 days agoSpirulina and chlorella are types of microalgae commonly taken in supplement form. They share some...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Average Target Price from Analysts
ETF DAILY NEWS· 1 day agoShares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat ...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks· 5 days agoFree Report) incurred a first-quarter 2024 loss of 54 cents per share, which matched the Zacks Consensus Estimate. Total revenues amounted to $172.3 million in the reported quarter, beating ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look
Guru Focus· 2 days agoOn May 9, 2024, Adverum Biotechnologies Inc (ADVM, Financial), a trailblazer in gene therapy for ocular diseases, disclosed its financial outcomes for the first quarter of 2024 through its 8 ...
Pascal Deschatelets Sells 78,907 Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Stock
ETF DAILY NEWS· 1 day agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) insider Pascal Deschatelets sold 78,907 shares of the firm’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%
ETF DAILY NEWS· 3 days agoSkye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...
Gut Bacteria Slip into the Eye
The Scientist· 3 days agoThe retina is layered with photoreceptors, a variety of other neurons, and protective and structural membranes, but retinal disorders can tamper with this delicate system. Mutations in the Crumbs ...
